This ‘Frontotemporal Dementia (FTD) - Epidemiology Forecast-2032' report delivers an in-depth understanding of FTD, historical and forecasted epidemiology as well as FTD trends in the United States, the EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.
A ‘definite' diagnosis of FTD is still based on neuropathology confirmation postmortem. Diagnostic markers currently used for FTD include imaging and blood or cerebrospinal fluid studies. They may best serve a diagnostic role when used in a multimodal approach to achieve a ‘definite' diagnosis of FTD in the living patient as soon as possible.
Frontotemporal Dementia Disease Understanding
FTD is a term used to describe a group of neurocognitive disorders that encompass progressive dysfunction in executive functioning, behavior, and language. There are three types of frontotemporal disorders (FTD): behavioral variant frontotemporal dementia (bvFTD), primary progressive aphasia (PPA), and movement disorders.
FTD occurs when brain cells in the frontal or temporal lobes die due to the build-up of abnormal proteins, leading to abnormal brain function, and more cell deaths result in brain atrophy. Many possible symptoms can result, including unusual behaviors, emotional problems, trouble communicating, difficulty with work, or difficulty with walking.Frontotemporal Dementia Diagnosis
FTD can be hard to diagnose as it displays clinical symptoms that can be mistaken for other dementias or psychiatric disorders. The average time from symptom onset to accurate diagnosis is about 3.6 years. Diagnosis of FTD currently includes Imaging and blood or cerebrospinal fluid studies.A ‘definite' diagnosis of FTD is still based on neuropathology confirmation postmortem. Diagnostic markers currently used for FTD include imaging and blood or cerebrospinal fluid studies. They may best serve a diagnostic role when used in a multimodal approach to achieve a ‘definite' diagnosis of FTD in the living patient as soon as possible.
Frontotemporal Dementia Epidemiology Perspective
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Diagnosed Prevalent Cases of Frontotemporal Dementia (FTD), Type-specific Diagnosed Prevalent Cases of Frontotemporal Dementia (FTD) and Gene-specific Diagnosed Prevalent Cases of Frontotemporal Dementia (FTD) in the 7MM covering the United States, the EU5 countries (Germany, France, Italy, Spain, and the United Kingdom) and Japan from 2019 to 2032.Key Findings
- Total diagnosed prevalent cases of FTD in the 7MM was found to be 128,570 in 2021, which might increase by the end of 2032. These cases are expected to increase at a CAGR of 0.3% during study period (2019-2032).
- Among 7MM, the United States has the highest prevalent cases of FTD with 58,960 cases in 2021.
- On the basis of type-specific diagnosed prevalent cases of FTD, bvFTD accounted for highest number of cases in 2021 with 35,846 cases in the United States.
- Among the European countries, Germany had the highest diagnosed prevalent population of FTD with 14,856 cases, followed by the France with 11,983 cases in 2021. On the other hand, Spain had the lowest diagnosed prevalent population.
- Japan accounted for 11,845 diagnosed prevalent cases of FTD in the year 2021 which are expected to decrease during the forecasted period (2022-2032).
Scope of the Report
- The report covers the descriptive overview of FTD, explaining its symptoms, etiology, pathogenesis, and various diagnostic approaches.
- The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
- The report assesses the disease risk and burden of FTD.
- The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.
- The report provides the segmentation of the disease epidemiology for 7MM diagnosed prevalent cases of frontotemporal dementia, type-specific diagnosed prevalent cases of frontotemporal dementia, and gene-specific diagnosed prevalent cases of frontotemporal dementia.
Report Highlights
- 11-Year Forecast of Frontotemporal Dementia
- The 7MM Coverage
- Total diagnosed prevalent cases of Frontotemporal Dementia
- Type-specific prevalent cases of Frontotemporal Dementia
- Gene-specific prevalent cases of Frontotemporal Dementia
Key Questions Answered
- What are the disease risk and burdens of Frontotemporal Dementia?
- What is the historical Frontotemporal Dementia patient pool in the United States, the EU5 (Germany, France, Italy, Spain, and the UK), and Japan?
- What would be the forecasted patient pool of Frontotemporal Dementia at the 7MM level?
- What will be the growth opportunities across the 7MM concerning the patient population about Frontotemporal Dementia?
- Out of the above-mentioned countries, which country would have the highest diagnosed prevalent population of Frontotemporal Dementia during the forecast period (2022-2032)?
- At what CAGR the population is expected to grow across the 7MM during the forecast period (2022-2032)?
Reasons to Buy
The Frontotemporal Dementia report will allow the user to -- Develop business strategies by understanding the trends shaping and driving the 7MM Frontotemporal Dementia epidemiology forecast.
- The Frontotemporal Dementia epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
- The Frontotemporal Dementia epidemiology model developed by the publisher is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the 11-year forecast period using reputable sources.
Key Assessments
- Patient Segmentation
- Disease Risk and Burden
- Risk of disease by the segmentation
- Factors driving growth in a specific patient population
Geographies Covered
- The United States
- The EU5 (Germany, France, Italy, Spain, and the United Kingdom)
- Japan
Table of Contents
1. Key Insights2. Report Introduction4. Patient Journey5. Executive Summary of Frontotemporal Dementia9. Publisher Capabilities10. Disclaimer11. About the Publisher
3. Frontotemporal Dementia (FTD) Patient Overview at a Glance
6. Disease Background and Overview: Frontotemporal Dementia
7. Epidemiology and Patient Population
8. Appendix
List of Tables
List of Figures
